Skip to main content
. Author manuscript; available in PMC: 2019 Sep 1.
Published in final edited form as: J Neuroimaging. 2018 May 24;28(5):530–534. doi: 10.1111/jon.12525

Table 2.

Markers of mass effect in patients with good versus poor outcome at day 90.

Patients with good outcome (mRS 0–2) Patients with poor outcome (mRS 3–6) p-value
n 29 42
Midline shift [mm] 0.0 (0.0 – 2.0) 2.1 (0.0 – 3.3) 0.007*
Lesional swelling volume [ml] 4.4 (1.1 – 10.2) 28.3 (8.8 – 53.3) <0.001*
Change in ipsilateral hemisphere volume [%] 1.5 (−1.6 – 3.6) 5.5 (1.2 – 9.1) 0.004*
Ratio hemisphere volumes FU 1.05 (1.04 – 1.09) 1.13 (1.07 – 1.18 ) <0.001*
Change in ipsilateral ventricle volume [%] −9.0 (−26.3 – 3.5) −21.2 (−41.4 – −1.9) 0.245
Ratio lateral ventricle volumes FU 0.86 (0.66 – 1.01) 0.7 (0.6 – 0.9) 0.046

Values are median (interquartile range); n = sample size; mRS = modified Rankin Scale; FU = follow-up. p-values are calculated with the Mann Whitney U test.

*

p <0.01